Your browser doesn't support javascript.
loading
Alopecia areata after ChAdOx1 nCoV-19 vaccine (Oxford/AstraZeneca): a potential triggering factor?
Essam, Reham; Ehab, Rana; Al-Razzaz, Radwa; Khater, Maha W; Moustafa, Emad A.
Affiliation
  • Essam R; Dermatology, Venereology and Andrology Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt.
  • Ehab R; Dermatology, Venereology and Andrology Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt.
  • Al-Razzaz R; General Dermatology Department, Cairo Hospital for Dermatology and Venereology (Al-Haud Al-Marsoud), Cairo, Egypt.
  • Khater MW; Medical Microbiology and Immunology Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt.
  • Moustafa EA; Tropical medicine Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt.
J Cosmet Dermatol ; 20(12): 3727-3729, 2021 Dec.
Article in En | MEDLINE | ID: mdl-34559937

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Alopecia Areata / COVID-19 Limits: Humans Language: En Journal: J Cosmet Dermatol Journal subject: DERMATOLOGIA Year: 2021 Document type: Article Affiliation country: Egypt

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Alopecia Areata / COVID-19 Limits: Humans Language: En Journal: J Cosmet Dermatol Journal subject: DERMATOLOGIA Year: 2021 Document type: Article Affiliation country: Egypt